YD Bio Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for YD Bio Limited (YDES) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022
Period EndingDec 2024Dec 2023Dec 2022
Current Assets
Cash and Cash Equivalents3.130.090.03
Cash & Short-Term Investments3.130.090.03
Accounts Receivable0.260.100.04
Inventory0.040.070.04
Other Current Assets0.030.000.00
Total Current Assets3.470.270.13
Non-Current Assets
Property, Plant & Equipment (Net)0.090.010.06
Long-Term Investments10.530.010.01
Intangible Assets2.680.000.00
Other Non-Current Assets-9.900.000.00
Total Non-Current Assets3.400.050.00
Total Assets6.860.320.23
Current Liabilities
Accounts Payable0.030.020.01
Short-Term Debt0.000.030.03
Current Portion of Long-Term Debt0.000.030.03
Accrued Liabilities0.220.010.01
Other Current Liabilities0.220.220.07
Total Current Liabilities0.260.300.17
Non-Current Liabilities
Long-Term Debt0.010.000.04
Deferred Tax Liabilities0.000.000.00
Other Non-Current Liabilities0.000.000.00
Total Non-Current Liabilities0.010.000.00
Total Liabilities0.270.300.22
Stockholders' Equity
Common Stock0.140.110.11
Retained Earnings-1.93-0.52-0.53
Accumulated Other Comprehensive Income0.050.050.05
Additional Paid-in Capital8.330.390.00
Shares Outstanding70.1070.100.00
Total Stockholders' Equity6.590.020.01
Total Liabilities & Equity6.860.320.00